Sorrento Therapeutics saw the highest growth of 1.24% in patent filings in May and 1.32% in grants in June in Q2 2024. Compared to Q1 2024, Q2 2024 saw an increase in patent filings by 0.39% and grants by 0.59%. GlobalData’s DataBook provides a comprehensive analysis of Sorrento Therapeutics‘s patent filings and grants. Buy the databook here.
Smarter leaders trust GlobalData
Sorrento Therapeutics has been focused on protecting inventions in United States(US) with eight publications in Q2 2024
The United States(US) Patent Office dominates the patent filings and grants with nearly 25% filings and 50% grants. The United States(US), European Patent Office(EPO), South Korea(KR), and China(CN) patent Office are among the top ten patent offices where Sorrento Therapeutics is filings its patents. Among the top granted patent authorities, Sorrento Therapeutics has 50% of its grants in United States(US), 20% in China(CN) and 20% in Canada(CA).
Roche could be the strongest competitor for Sorrento Therapeutics
Patents related to cell & gene therapy and rare diseases lead Sorrento Therapeutics's portfolio
Sorrento Therapeutics has the highest number of patents in cell & gene therapy followed by, rare diseases and nanomedicine. For cell & gene therapy, nearly 33% of patents were filed and no patents were granted in Q2 2024.
Drug delivery devices related patents lead Sorrento Therapeutics portfolio followed by cell therapy, and coronavirus disease 2019 (covid-19)
Sorrento Therapeutics has highest number of patents in drug delivery devices followed by cell therapy, coronavirus disease 2019 (covid-19), multiple myeloma (kahler disease), and viral infections. For drug delivery devices, nearly 7% of patents were filed and 17% of patents were granted in Q2 2024.
For comprehensive analysis of Sorrento Therapeutics's filings and grants, buy the databook here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData patents database covers bibliographic from all 100+ patenting authorities. All patents are tagged to 18+ industries and 300+ sub-sectors based on technology classification, keywords, and associated companies. They are also tagged to various industries themes (100+) and technology domains (1800+) of focus.
Patents database further disambiguates assignee names (13m names) and associate corporate tree hierarchy in current/point in time ownerships (320k entities). GlobalData sources content directly from national patent offices on a weekly basis.
